Wegovy Just like with semaglutide, tirzepatide has two brand names: Mounjaro: FDA-approved for Type 2 Diabetes Maximum dose: 15 mg weekly Prescribed primarily for blood sugar control Zepbound: FDA-approved for weight management Same maximum dose: 15 mg weekly Marketed for obesity treatment The drugs are chemically identical, but the legal considerations mirror the Ozempic/Wegovy distinction: Different labels and warnings Different approved uses Potential off-label prescribing Different marketing claims Case Example: Tirzepatide Injury Patient Profile: 52-year-old woman with BMI 34 No diabetes, seeking weight loss Prescribed Zepbound, escalated to 15 mg Timeline: Month 1-3: Excellent weight loss (25 lbs), manageable nausea Month 4: Persistent vomiting began Month 5: Unable to eat solid food, lost 15 more lbs Month 6: Diagnosed with severe gastroparesis via gastric emptying scan Current: 12 months post-discontinuation, still cannot eat normally, requires liquid diet Legal Claim: Inadequate warnings about permanence of gastroparesis Marketing emphasized dramatic weight loss without proper risk disclosure Failure to inform that condition might not resolve after stopping Damages include ongoing medical care, lost wages, diminished quality of life 5
Further Reading Wegovy: Heres When Supply Of The Weight Loss Drug Could Improve This Year (Forbes) List Price Of Ozempic And Other Drugs Reportedly Rise: Heres What That Means For Consumers (Forbes) As Zepbound shortage grows, Eli Lilly says no immediate end is in sight (NBC News)
Mold and Mycotoxin Exposure Symptoms Non-toxic and toxic mold symptoms can show up differently for each person
Recalls & Warnings August 27, 2012 Protein Drinks Recalled For Undeclared Milk Source On August 24, 2012, True Nutrition issued a recall of Whey Protein Concentrate, Whey Protein Isolate Cold-Filtration, Whey Protein Isolate Micro-Filtrated, Whey Protein Isolate Cross-Flow Microfiltration and Hydrolyzed Whey Protein High Grade because labels for these products do not declare milk as
.png)
